Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $7.32 and traded as low as $4.09. Mannatech shares last traded at $4.21, with a volume of 19,477 shares trading hands.
Mannatech Stock Performance
The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.59 and a current ratio of 1.09. The firm has a market capitalization of $8.13 million, a price-to-earnings ratio of -0.63 and a beta of 0.61. The stock’s fifty day moving average is $5.62 and its two-hundred day moving average is $7.32.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.49 EPS for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The firm had revenue of $24.92 million for the quarter.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
See Also
- Five stocks we like better than Mannatech
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
